Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    82.74
    -0.07 (-0.08%)
     
  • Bitcoin CAD

    88,030.28
    -3,349.34 (-3.67%)
     
  • CMC Crypto 200

    1,383.53
    -40.57 (-2.85%)
     
  • GOLD FUTURES

    2,332.00
    -6.40 (-0.27%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,468.50
    -196.00 (-1.11%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,788.49
    -671.59 (-1.75%)
     
  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

1 Top Healthcare Stock That Could Make You Richer in the Next Decade

1 Top Healthcare Stock That Could Make You Richer in the Next Decade

On that note, Pfizer (NYSE: PFE) has a habit of making its investors wealthier via its dividends and share repurchasing activity, and there's no reason to suspect that'll change through at least 2030. If you invested $5,000 in Pfizer a decade ago, right now you'd be happy to see that its total return in that period was around $10,900. In the next 10 years, there's no guarantee that it'll repeat that exact performance, but there are reasons to believe that it'll still be a good stock to own for the purposes of collecting its dividend and perhaps also experiencing share price appreciation over the long run.